2021 was the busiest year for deals since 2000, with a record-breaking IPO rush of 1,035 listings in the US, with the biotech and healthcare sectors leading the way, accounting for 36% of all IPO activity.
RGC’s Solid Foundation
As mentioned above, RGC is closely held by the CEO who owns over 81% of the company. He has used $5.9 million of his personal funds to purchase RGC shares from the open market since its IPO.
His consistent share purchases convey his confidence, commitment and conviction in the company and is putting his money where his mouth is. There are few companies that have the CEO owning this much of the business. The company’s entire management team has also extended the lock-up period of their share options, which shows they are collectively committed to their goal and mission, which is to save and improve lives.
Comparison to 2022 IPO Top Performer
HKD’s upward trajectory which has delivered an incredible 90 times bagger in a short amount of time has also attracted many short positions against the company. Below is a table outlining the key metrics:
Daily short volume (%) refers to the number of shares that have been shorted as compared to the total daily volume traded.
RGC and HKD Comparison Chart
RGC’s Stock Chart Since IPO:
RGC’s Daily Short Volume Ratio (1 month) (7):
RGC’s Daily Short Volume Ratio (1 year) (7):
HKD’s Stock Chart Since IPO:
HKD’s Daily Short Volume Ratio (1 month) (8):
Source:
(1) https://www.nasdaq.com/market-activity/ipos/overview?dealId=1151577-96813
(2)https://www.nasdaq.com/market-activity/ipos/overview?dealId=1160165-97666
(3)https://stockanalysis.com/ipos/2021/
(4)https://stockanalysis.com/ipos/2022/
(5)https://www.sec.gov/Archives/edgar/data/1829667/000121390022041491/ea163338-13da5regen_regen.htm
(6)https://www.sec.gov/Archives/edgar/data/0001809691/000119312522194790/d943653d424b4.htm#rom943653_19
(7)https://shortvolume.com/?t=rgc
(8)https://shortvolume.com/?t=hkd
Featured image sourced from Shutterstock
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
